Shared metabolic and neuroimmune mechanisms underlying Type 2 Diabetes Mellitus and Major Depressive Disorder
Version 2 2024-06-13, 16:55Version 2 2024-06-13, 16:55
Version 1 2022-09-28, 10:32Version 1 2022-09-28, 10:32
journal contribution
posted on 2022-09-28, 10:32authored byE Duarte-Silva, M G de Melo, Michael Maes, A J M C Filho, D Macedo, C A Peixoto
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease with symptoms that go beyond the domain of glucose metabolism. In fact, research has shown that T2DM is accompanied by neurodegeneration and neuroinflammation. Interestingly, Major Depressive Disorder (MDD), a mood disorder characterized mainly by depressed mood and anhedonia is a key feature of T2DM. A body of evidence demonstrates that there are many shared neuroimmune mechanisms underlying the pathophysiology of T2DM and MDD. Therefore, here we review the state-of-art regarding the underlying factors common to both T2DM and MDD. Furthermore, we briefly discuss how depressive symptoms in diabetic patients could be tackled by using novel therapeutic approaches uncovered by these shared mechanisms. Understanding the comorbidity of depression in diabetic patients is essential to fully address T2DM pathophysiology and treatment.
History
Journal
Progress in Neuro-Psychopharmacology and Biological Psychiatry